Cytosorbents Crp Stock Price Prediction

CTSO Stock  USD 0.97  0.06  6.59%   
As of today, the relative strength index (RSI) of Cytosorbents Crp's share price is approaching 43 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Cytosorbents Crp, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
The successful prediction of Cytosorbents Crp's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Cytosorbents Crp, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cytosorbents Crp's stock price prediction:
EPS Estimate Next Quarter
(0.05)
EPS Estimate Current Year
(0.30)
EPS Estimate Next Year
(0.14)
Wall Street Target Price
5
EPS Estimate Current Quarter
(0.06)
Using Cytosorbents Crp hype-based prediction, you can estimate the value of Cytosorbents Crp from the perspective of Cytosorbents Crp response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cytosorbents Crp to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytosorbents because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cytosorbents Crp after-hype prediction price

    
  USD 0.97  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Cytosorbents Crp Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytosorbents Crp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.132.628.84
Details
2 Analysts
Consensus
LowTargetHigh
6.987.678.51
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.07-0.07-0.07
Details

Cytosorbents Crp After-Hype Price Prediction Density Analysis

As far as predicting the price of Cytosorbents Crp at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytosorbents Crp or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cytosorbents Crp, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Cytosorbents Crp Estimiated After-Hype Price Volatility

In the context of predicting Cytosorbents Crp's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytosorbents Crp's historical news coverage. Cytosorbents Crp's after-hype downside and upside margins for the prediction period are 0.05 and 7.19, respectively. We have considered Cytosorbents Crp's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.97
0.97
After-hype Price
7.19
Upside
Cytosorbents Crp is dangerous at this time. Analysis and calculation of next after-hype price of Cytosorbents Crp is based on 3 months time horizon.

Cytosorbents Crp Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Cytosorbents Crp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytosorbents Crp backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytosorbents Crp, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.11 
6.22
 0.00  
 0.00  
8 Events / Month
13 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.97
0.97
0.00 
31,100  
Notes

Cytosorbents Crp Hype Timeline

Cytosorbents Crp is currently traded for 0.97. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cytosorbents is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.11%. %. The volatility of related hype on Cytosorbents Crp is about 16686.79%, with the expected price after the next announcement by competition of 0.97. About 33.0% of the company shares are held by institutions such as insurance companies. The book value of Cytosorbents Crp was currently reported as 0.24. The company recorded a loss per share of 0.36. Cytosorbents Crp had not issued any dividends in recent years. The entity had 1:25 split on the 5th of December 2014. Given the investment horizon of 90 days the next projected press release will be in about 8 days.
Check out Cytosorbents Crp Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

Cytosorbents Crp Related Hype Analysis

Having access to credible news sources related to Cytosorbents Crp's direct competition is more important than ever and may enhance your ability to predict Cytosorbents Crp's future price movements. Getting to know how Cytosorbents Crp's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytosorbents Crp may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
OSAProSomnus, Common Stock 0 1 per month 13.81  0.13  51.22 (20.31) 168.97 
LIVNLivaNova PLC 0.87 8 per month 1.49  0  3.53 (2.55) 8.68 
ELMDElectromed(0.02)10 per month 1.58  0.34  6.13 (3.70) 12.73 
KIDSOrthopediatrics Corp(0.76)10 per month 0.00 (0.12) 4.85 (5.08) 16.62 
SRDXSurModics(0.07)6 per month 0.00 (0.21) 1.26 (1.01) 3.22 
NPCENeuropace 0.13 11 per month 3.01  0.09  9.73 (6.19) 35.38 
CLPTClearpoint Neuro 0.13 9 per month 3.51 (0.03) 6.76 (3.91) 24.80 
TELATela Bio(0.02)8 per month 2.69  0.01  6.43 (4.83) 15.40 
CVRXCVRx Inc(0.78)10 per month 3.48  0.11  10.68 (8.22) 41.08 
OFIXOrthofix Medical 0.15 8 per month 2.06  0.03  3.90 (3.85) 12.11 
AORTArtivion(0.05)8 per month 1.51  0.03  2.65 (2.63) 9.51 
HSKAHeska 0.15 8 per month 0.00  0.17  3.63 (0.71) 21.36 
FNAParagon 28(0.08)6 per month 4.10  0.06  7.32 (6.30) 43.16 
INGNInogen Inc(0.13)6 per month 0.00 (0.17) 3.57 (4.81) 22.50 
LUNGPulmonx Corp(0.05)8 per month 0.00 (0.06) 8.44 (6.89) 20.44 
APYXApyx Medical(0.07)7 per month 3.37  0.05  10.00 (6.45) 32.02 

Cytosorbents Crp Additional Predictive Modules

Most predictive techniques to examine Cytosorbents price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytosorbents using various technical indicators. When you analyze Cytosorbents charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cytosorbents Crp Predictive Indicators

The successful prediction of Cytosorbents Crp stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytosorbents Crp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytosorbents Crp based on analysis of Cytosorbents Crp hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytosorbents Crp's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytosorbents Crp's related companies.
 2023 2024 (projected)
Dividend Yield0.0021510.002043
Price To Sales Ratio1.361.3

Story Coverage note for Cytosorbents Crp

The number of cover stories for Cytosorbents Crp depends on current market conditions and Cytosorbents Crp's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytosorbents Crp is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytosorbents Crp's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cytosorbents Crp Short Properties

Cytosorbents Crp's future price predictability will typically decrease when Cytosorbents Crp's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytosorbents Crp often depends not only on the future outlook of the potential Cytosorbents Crp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytosorbents Crp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding44.7 M
Cash And Short Term Investments14.1 M
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out Cytosorbents Crp Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.36)
Revenue Per Share
0.72
Quarterly Revenue Growth
0.066
Return On Assets
(0.28)
Return On Equity
(1.19)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.